Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-032340
Filing Date
2026-03-20
Accepted
2026-03-20 16:05:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 ea028279301-424b3_enlivex.htm 424B3 7232
2 GRAPHIC image_001.jpg GRAPHIC 6056
  Complete submission text file 0001213900-26-032340.txt   17113
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286956 | Film No.: 26778250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)